Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Cryoprecipitate units"'
Publikováno v:
Russian journal of hematology and transfusiology. 64:16-20
Aim. To determine the dynamics of cryoprecipitate production in Russian blood service institutions in comparison with such institutions in other countries.Materials and methods. Reports provided by Russian blood service institutions during the 1997
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb94753c67a4fb145f9c7dd035381da3
https://doi.org/10.35754/0234-5730-2019-64-1-16-20
https://doi.org/10.35754/0234-5730-2019-64-1-16-20
Publikováno v:
Cardiovascular Journal of Africa. 29:381-386
BACKGROUND Cardiac surgery is associated with peri-operative bleeding, which may result in the need for blood transfusion, particularly in paediatric congenital cardiac surgery on cardiopulmonary bypass (CPB). There is a necessity for regular auditin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec11a43a734ff4605f872106dd40ac3a
https://doi.org/10.5830/cvja-2018-048
https://doi.org/10.5830/cvja-2018-048
Publikováno v:
Blood. 138:4278-4278
Background Cryoprecipitate is an important blood product derived from fresh frozen plasma. It is primarily used to replenish fibrinogen levels in patients. Currently, there is a lack of studies characterising nano-sized particles, including extracell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbfdac600be32deb8274144b97cd2231
https://doi.org/10.1182/blood-2021-147793
https://doi.org/10.1182/blood-2021-147793
Publikováno v:
Vox Sanguinis. 110:12-19
Background and Objective Cryoprecipitate is a concentrated source of fibrinogen and other plasma proteins. Cryoprecipitate must be transfused within 4–6 h of thawing and storage at 20–24°C. We compared plasma protein activities in single or pool
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62ce21d2531e767dba59e723b4d81815
https://doi.org/10.1111/vox.12309
https://doi.org/10.1111/vox.12309
Publikováno v:
Vox sanguinis. 112(5)
Although key coagulation factor activities are maintained in thawed cryoprecipitate stored for up to 24 h at ambient temperature, several jurisdictions limit such storage to 4-6 h. Here, we separately spiked thawed cryoprecipitate units with four bac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3840f10586f1256849c02379ec5eeab5
https://pubmed.ncbi.nlm.nih.gov/28382701
https://pubmed.ncbi.nlm.nih.gov/28382701
Publikováno v:
Transfusion. 51:58S-64S
BACKGROUND: The quality of blood components prepared from whole blood (WB) units rapidly cooled to 20 to 24°C and stored for prolonged periods using butane-1,4-diol “cooling plates,” and the factors that determine the functional activity of thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9926f669e6239566e13c1ea7c2f21fd9
https://doi.org/10.1111/j.1537-2995.2010.02964.x
https://doi.org/10.1111/j.1537-2995.2010.02964.x
Publisher Summary Cryoprecipitate is the insoluble cold precipitate formed when fresh frozen plasma (FFP) is thawed between 1 and 6°C. The recovered precipitate is then refrozen in 10–15 ml of plasma within 1 hour of separation and stored at –18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53fb9628c8c4ba8b7b8b329cb57f7743
https://doi.org/10.1016/b978-012348775-9/50057-0
https://doi.org/10.1016/b978-012348775-9/50057-0
Publikováno v:
Transfusion medicine (Oxford, England). 4(1)
SUMMARY. To improve the appropriateness of blood-component prescribing, a mandatory haematologist pretransfusion approval programme of all non-red-cell components was instituted. This was associated with a 33% decrease in the units of fresh frozen pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e300e2630d0bb5c749517c2422bf8d8
https://pubmed.ncbi.nlm.nih.gov/8012492
https://pubmed.ncbi.nlm.nih.gov/8012492
Autor:
Paul Jenner, Maureane Hoffman
Publikováno v:
Scopus-Elsevier
Advances in the preparation of commercial Factor VIII concentrates have decreased the clinical use of cryoprecipitate to replace Factor VIII coagulant activity. Cryoprecipitate is now frequently transfused as a source of fibrinogen or von Willebrand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c621503557caee44f8c7cab76c9543e
https://pubmed.ncbi.nlm.nih.gov/2327369
https://pubmed.ncbi.nlm.nih.gov/2327369
Autor:
Ja A. Spero, Fa A. Bontempo, F.W. Cornell, Je E. Kiss, P. Larson, Mv V. Ragni, Eo O. Rice, T. E. Starzl, J.H. Lewis
Publikováno v:
Transfusion. 27:222-225
During the first 5 years (1981-1985) of the liver transplantation program in Pittsburgh, a total (preoperative, intraoperative, and postoperative) of 18,668 packed red cell units, 23,627 fresh-frozen plasma units, 20,590 platelet units, and 4241 cryo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44158768075ed5b5efa2d4d8611154d0
https://doi.org/10.1046/j.1537-2995.1987.27387235624.x
https://doi.org/10.1046/j.1537-2995.1987.27387235624.x